Scarica l'app Stockscreener
29.68
3.67%
1.07
Precedente Chiudi:
$28.61
Aprire:
$28.63
Volume 24 ore:
380.06K
Relative Volume:
0.27
Capitalizzazione di mercato:
$2.33B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-39.57
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+0.78%
1M Prestazione:
+18.55%
6M Prestazione:
-14.67%
1 anno Prestazione:
-6.20%
Intervallo 1D:
$28.55
$29.72
Intervallo di 1 settimana:
$28.25
$31.30
Portata 52W:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta VCYT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
29.68 | 2.29B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
487.06 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.62 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.97 | 51.27B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.17 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.50 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Live market analysis of Veracyte Inc.Inflation Watch & Expert Approved Trade Ideas - Newser
Can Veracyte Inc. hit a new high this monthJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Using data filters to optimize entry into Veracyte Inc.Portfolio Growth Summary & Community Supported Trade Ideas - Newser
Why Veracyte Inc. is moving todayQuarterly Trade Report & Low Risk Entry Point Guides - Newser
Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer - BioSpace
Is it time to cut losses on Veracyte Inc.July 2025 Action & Stepwise Trade Signal Implementation - Newser
Is Veracyte Inc. stock ready for a breakoutJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Veracyte Inc.’s volatility index tracking explainedJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - Newser
Published on: 2025-08-27 20:20:11 - Newser
Forecasting Veracyte Inc. price range with options dataJuly 2025 Analyst Calls & High Yield Equity Trading Tips - Newser
Understanding Veracyte Inc.’s price movementEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
What machine learning models say about Veracyte Inc.Earnings Growth Summary & Low Drawdown Investment Ideas - Newser
Is a relief rally coming for Veracyte Inc. holdersJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Veracyte’s Decipher Prostate Test: A Precision Medicine Game-Changer in Metastatic Prostate Cancer - AInvest
Veracyte's Decipher Prostate Test: Redefining Precision Medicine in Prostate Cancer and Unlocking New Revenue Streams - AInvest
Real time breakdown of Veracyte Inc. stock performanceJuly 2025 Selloffs & AI Driven Price Predictions - Newser
36% Higher Survival Rate: Groundbreaking Veracyte Test Revolutionizes Prostate Cancer Treatment Selection - Stock Titan
Should you hold or exit Veracyte Inc. nowQuarterly Trade Summary & AI Forecasted Entry and Exit Points - Newser
Veracyte completes enrollment for lung nodule test trial By Investing.com - Investing.com Nigeria
Is Veracyte Inc. forming a reversal patternFed Meeting & Fast Gain Stock Trading Tips - Newser
Veracyte shares rise 1.58% after-hours after completing enrollment for NIGHTINGALE clinical utility trial. - AInvest
Measuring Veracyte Inc.’s beta against major indicesJuly 2025 Decliners & Verified Momentum Stock Ideas - Newser
Veracyte: Q2 Earnings Brings My Position Out Of Mothballs (NASDAQ:VCYT) - Seeking Alpha
Veracyte Completes Enrollment for Clinical Utility Trial to Evaluate Nasal Swab Lung Cancer Test - MarketScreener
Veracyte completes enrollment for lung nodule test trial - Investing.com
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test. - AInvest
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test - Business Wire
Momentum divergence signals in Veracyte Inc. chartQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
Developing predictive dashboards with Veracyte Inc. dataMarket Sentiment Summary & Breakout Confirmation Trade Signals - Newser
Earnings visualization tools for Veracyte Inc.Market Activity Summary & Expert Verified Stock Movement Alerts - Newser
Can Veracyte Inc. recover in the next quarter2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
Volatility clustering patterns for Veracyte Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Short Term Charts Align With Long Term Uptrend in Veracyte Inc.Trade Signal Summary & AI Enhanced Execution Alerts - beatles.ru
Published on: 2025-08-25 23:28:31 - Newser
Analyzing drawdowns of Veracyte Inc. with statistical toolsJuly 2025 Final Week & Technical Pattern Recognition Alerts - Newser
Is the Options Market Predicting a Spike in Veracyte Stock? - sharewise.com
Real time alert setup for Veracyte Inc. performanceTreasury Yields & AI Powered Trade Plan Recommendations - Newser
How Resilient Is Veracyte Inc. Stock During Economic Downturns2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Custom strategy builders for tracking Veracyte Inc.July 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
Can Veracyte Inc. expand into new marketsJuly 2025 Breakouts & High Accuracy Investment Signals - theviewers.co.kr
What momentum shifts mean for Veracyte Inc.Weekly Earnings Recap & Proven Capital Preservation Tips - Newser
Will Veracyte Inc. Recover After Recent Decline2025 Biggest Moves & Weekly High Return Opportunities - classian.co.kr
How Investors May Respond To Veracyte (VCYT) Earnings Upgrades and Spotlight as a Momentum Stock - Yahoo Finance
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Veracyte Inc Azioni (VCYT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bhanji Muna | Director |
Jun 13 '25 |
Sale |
26.67 |
4,589 |
122,367 |
29,989 |
0.53%
2.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):